Abstract
Adenosine diphosphate (ADP) and prostaglandin derivatives play important roles in thrombogenesis. Their roles in platelet function have been extensively studied for more than three and two decades, respectively. Of further importance for thrombogenesis, and perhaps for atherogenesis as well, is that these compounds are involved in the regulation of vascular wall tone, both as constrictors and dilators. The aim of this brief essay is to highlight the relative importance of ADP and TxA various well-defined shear conditions. To achieve this goal, we employed a human ex vivo model of thrombus formation, because well-defined and reproducible blood shear conditions are best created in such a device. The blood flow conditions varied from those encountered atherosclerotic disease. These experiments were performed as parts of clinical phase I studies with novel antagonists of ADP- or TxA-induced platelet aggregation. Probes for ADP and TxA 2 receptor antagonist clopidogrel and the TxA receptor 2 rombotic activities were compared with results obtained with the cyclo-oxygenase inhibitor aspirin. These studies demonstrated a significant effect of both ADP and TxA formation. W hereas ADP promoted platelet thrombus formation independently of the local shear, TxA promoted platelet thrombus formation at high arterial shear only, and increasingly by increasing shear. However, at blood flow conditions triggering shear-induced formation did not affect collagen-induced platelet thrombus formation since aspirin administration was insensitive to the thrombotic response. This contrasts with the need for ADP in shear-induced platelet aggregation. Thus, the function of ADP in human ex vivo platelet thrombus formation appears more global than the role of TxA . These observations are in agreement with recent published clinical findings. 2 in collagen-induced thrombus formation at 2 in healthy veins to vessels with severe included the ADP 2 antagonist linotroban, respectively. Their antithon collagen-induced ex vivo thrombus 2 2 platelet activation and aggregation, TxA 2
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.